Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
nausea,	O
Shortness	O
of	O
breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Valvulosplasty	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
F	O
with	O
critical	O
AS,	O
CAD	O
s/p	O
CABG	O
presented	O
with	O
increased	O
DOE	O
and	O
volume	O
overload.	O
.	O
Pt	O
was	O
not	O
a	O
good	O
historian.	O
She	O
had	O
a	O
fall	B-Falls
on	O
___	O
and	O
was	O
recently	O
hospitalized	O
for	O
C.diff	O
colitis	O
between	O
___	O
to	O
___,	O
and	O
was	O
discharged	O
with	O
flagyl	O
to	O
___.	O
Prior	O
to	O
that	O
pt	O
lived	O
at	O
___	O
and	O
was	O
reportedly	O
very	O
functional,	O
and	O
exercised	O
3X	O
a	O
week.	O
In	O
the	O
past	O
month,	O
pt	O
repeated	O
complained	O
of	O
feeling	O
"nauseous",	O
and	O
she	O
attributed	O
to	O
not	O
getting	O
correct	O
O2	O
through	O
nasal	O
canula.	O
Pt	O
also	O
not	O
notably	O
less	O
active,	O
and	O
fatigue	O
easier.	O
She	O
denied	O
CP.	O
Per	O
discussion	O
with	O
her	O
daughter,	O
she	O
found	O
that	O
patient	O
was	O
significantly	O
more	O
confused,	B-Delirium
with	O
noticeably	O
worsening	O
tremor,	O
and	O
more	O
kyphotic.	O
.	O
Of	O
note,	O
pt	O
had	O
critical	O
aortic	O
stenosis.	O
In	O
___,	O
she	O
had	O
area	O
0.5,	O
gradient	O
43	O
and	O
peak	O
velocity	O
4.9.	O
She	O
underwent	O
valulaplasty	O
with	O
improvement	O
to	O
1.0/21/3.3.	O
Her	O
last	O
ECHO	O
yeseterday	O
showed	O
EF	O
of	O
30%	O
with	O
aortic	O
valve	O
0.8/34/4.	O
At	O
the	O
rehab,	O
her	O
lasix	O
dose	O
increased	O
from	O
20	O
mg	O
qd	O
to	O
100	O
mg	O
qd.	O
Pt	O
was	O
directly	O
admitted	O
from	O
the	O
rehab	O
given	O
concerns	O
of	O
singificant	O
volume	O
overload	O
from	O
AS	O
induced	O
heart	O
failure.	O
.	O
On	O
review	O
of	O
systems,	O
Pt	O
denies	O
recent	O
fevers,	O
chills,	O
rigors,	O
diarrhea,	O
or	O
recent	O
sickness.	O
She	O
denies	O
chest	O
pain.	O
She	O
uses	O
___	O
pillows	O
for	O
sleep,	O
has	O
positive	O
orthopnea	O
and	O
PND.	O
She	O
denies	O
any	O
LOC	O
or	O
syncope	O
Past	O
Medical	O
History:	O
1.	O
CAD,	O
Severe	O
aortic	O
stenosis	O
with	O
___	O
of	O
0.8	O
cm2,	O
CABG:	O
3V	O
CABG	O
recent	O
catheterization	O
with	O
widening	O
of	O
her	O
aortic	O
valvuloplasty	O
___	O
complicated	O
by	O
CVA.	O
2.	O
Diabetes	O
mellitus	O
type	O
2.	O
3.	O
Hypertension	O
4.	O
Hyperlipidemia.	O
5.	O
Ischemic	O
and	O
valvular	O
cardiomyopathy	O
with	O
an	O
EF	O
___	O
6.	O
History	O
of	O
left	O
breast	O
cancer,	O
grade	O
3.	O
7.	O
Right	O
rotator	O
cuff	O
tendinopathy.	O
8.	O
Right	O
biceps	O
tendinitis.	O
9.	O
Polymyalgia	O
rheumatica.	O
10.	O
Osteoporosis.	O
11.	O
Moderate	O
mitral	O
regurgitation	O
12.	O
History	O
of	O
squamous	O
cell	O
carcinoma.	O
13.	O
Moderate	O
MR	O
14.	O
Severe	O
AS:	O
symptoms	O
started	O
in	O
___	O
15.	O
Atrial	O
fibrillation:	O
coumadin,	O
amiodarone	O
.	O
PAST	O
SURGICAL	O
HISTORY:	O
1.	O
Right	O
mastectomy.	O
2.	O
Coronary	O
artery	O
bypass	O
graft	O
___	O
years	O
ago.	O
3.	O
Hysterectomy.	O
4.	O
Excision	O
of	O
left	O
dorsal	O
hand	O
squamous	O
cell	O
carcinoma.	O
5.	O
Right	O
fourth	O
trigger	O
finger	O
release.	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
history	O
of	O
early	O
MI,	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death;	O
otherwise	O
non-contributory.	O
Physical	O
Exam:	O
ADMISSION	O
EXAM	O
VS:	O
97.4,	O
124/63,	O
76,	O
16,	O
90%	O
on	O
2L	O
GENERAL:	O
Alert	B-Delirium
and	B-Delirium
Oriented	B-Delirium
x3.	B-Delirium
NAD,	O
Frail	B-Frailty
appearing	O
lovely	O
lady	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL,	O
EOMI.	O
Conjunctiva	O
were	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthalesma.	O
MM	O
dry,	O
OP	O
clear	O
NECK:	O
Supple	O
with	O
JVP	O
~10	O
cm,	O
no	O
LAD,	O
no	O
thyroimegaly	O
CARDIAC:	O
PMI	O
located	O
in	O
___	O
intercostal	O
space,	O
midclavicular	O
line.	O
RR,	O
postive	O
heaves,	O
good	O
S1,	O
S2	O
with	O
___	O
systolic	O
murmur	O
best	O
heard	O
at	O
RUSB	O
with	O
minimal	O
radiation	O
to	O
carotids.	O
LUNGS:	O
Decreased	O
breath	O
sound	O
to	O
base,	O
left	O
worse	O
than	O
right,	O
bibasilar	O
crackles.	O
ABDOMEN:	O
Soft,	O
NTND.	O
No	O
HSM,	O
mild	O
RUQ	O
tenderness,	O
no	O
___	O
sign,	O
no	O
rebound	O
or	O
guarding	O
EXTREMITIES:	O
pitting	O
edema	O
to	O
mid	O
thign	O
bilaterally	O
PULSES:	O
Right:	O
DP	O
1+	O
___	O
1+	O
Left:	O
DP	O
1+	O
___	O
1+	O
SKIN:	O
a	O
~4cm	O
sutured	O
lesion	O
over	O
right	O
shin	O
with	O
clean	O
gauze,	O
wound	O
appears	O
clean	O
intact	O
with	O
minimal	O
erythma	O
or	O
edema.	O
NEURO:	O
pos	O
asterixis	O
.	O
DISCHARGE	O
EXAM	O
VSS,	O
O2	O
sat	O
>	O
98%	O
on	O
2L	O
O2	O
GEN:	O
A	B-Delirium
&	B-Delirium
OX3,	B-Delirium
NAD	O
NECK:	O
supple,	O
JVP	O
flat	O
HEART:	O
RRR,	O
___	O
SEM	O
with	O
radiation	O
to	O
carotids,	O
___	O
holosystolic	O
murmur	O
with	O
radiation	O
to	O
axilla	O
LUNG:	O
bilaterally	O
crackles	O
in	O
lower	O
___	O
to	O
___ecreased	O
air	O
movement	O
in	O
base,	O
left	O
worse	O
than	O
right	O
ABD:	O
soft,	O
NT/ND,	O
no	O
HSM	O
EXT:	O
1+	O
pitting	O
edema	O
to	O
thigh	O
bilaterally	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
___	O
12:40PM	O
BLOOD	O
WBC-6.2	O
RBC-3.48*	O
Hgb-10.9*	O
Hct-34.4*	O
MCV-99*#	O
MCH-31.3#	O
MCHC-31.6	O
RDW-15.8*	O
Plt	O
___	O
___	O
12:40PM	O
BLOOD	O
___	O
PTT-31.0	O
___	O
___	O
12:40PM	O
BLOOD	O
UreaN-39*	O
Creat-1.3*	O
Na-145	O
K-4.2	O
Cl-94*	O
HCO3-43*	O
AnGap-12	O
___	O
12:40PM	O
BLOOD	O
ALT-17	O
AST-24	O
CK(CPK)-21*	O
AlkPhos-79	O
TotBili-0.6	O
___	O
12:40PM	O
BLOOD	O
CK-MB-2	O
___	O
___	O
04:10PM	O
BLOOD	O
Calcium-9.8	O
Phos-5.0*#	O
Mg-2.1	O
.	O
CARDIAC	O
MARKERS	O
___	O
12:40PM	O
BLOOD	O
CK-MB-2	O
___	O
___	O
07:20PM	O
BLOOD	O
CK-MB-2	O
cTropnT-0.01	O
___	O
07:44AM	O
BLOOD	O
CK-MB-2	O
cTropnT-0.01	O
.	O
ARTERIAL	O
GAS	O
___	O
03:57PM	O
BLOOD	O
Type-ART	O
Temp-36.7	O
pO2-64*	O
pCO2-72*	O
pH-7.41	O
calTCO2-47*	O
Base	O
XS-16	O
Intubat-NOT	O
INTUBA	O
___	O
03:24PM	O
BLOOD	O
Type-ART	O
Temp-36.7	O
pO2-61*	O
pCO2-78*	O
pH-7.41	O
calTCO2-51*	O
Base	O
XS-19	O
Intubat-NOT	O
INTUBA	O
.	O
DISCHARGE	O
LABS	O
___	O
05:54AM	O
BLOOD	O
WBC-3.5*	O
RBC-2.83*	O
Hgb-8.7*	O
Hct-28.4*	O
MCV-101*	O
MCH-30.7	O
MCHC-30.5*	O
RDW-15.4	O
Plt	O
___	O
___	O
05:54AM	O
BLOOD	O
Glucose-94	O
UreaN-45*	O
Creat-1.5*	O
Na-143	O
K-3.5	O
Cl-99	O
HCO3-39*	O
AnGap-9	O
___	O
05:54AM	O
BLOOD	O
Calcium-8.8	O
Phos-5.0*	O
Mg-2.4	O
.	O
PERTINENT	O
STUDIES	O
ECHO	O
___	O
The	O
left	O
atrium	O
is	O
moderately	O
dilated.	O
There	O
is	O
moderate	O
symmetric	O
left	O
ventricular	O
hypertrophy.	O
The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal.	O
LV	O
systolic	O
function	O
appears	O
moderately-to-severely	O
depressed	O
(ejection	O
fraction	O
30	O
percent)	O
with	O
regional	O
variation.	O
Tissue	O
Doppler	O
imaging	O
suggests	O
an	O
increased	O
left	O
ventricular	O
filling	O
pressure	O
(PCWP>18mmHg).	O
The	O
right	O
ventricular	O
free	O
wall	O
is	O
hypertrophied.	O
Right	O
ventricular	O
chamber	O
size	O
is	O
normal.	O
with	O
depressed	O
free	O
wall	O
contractility.	O
There	O
are	O
focal	O
calcifications	O
in	O
the	O
aortic	O
arch.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
severely	O
thickened/deformed.	O
There	O
is	O
severe	O
aortic	O
valve	O
stenosis	O
(valve	O
area	O
0.8	O
cm2).	O
Mild	O
(1+)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Moderate	O
to	O
severe	O
(3+)	O
mitral	O
regurgitation	O
is	O
seen.	O
[Due	O
to	O
acoustic	O
shadowing,	O
the	O
severity	O
of	O
mitral	O
regurgitation	O
may	O
be	O
significantly	O
UNDERestimated.]	O
Due	O
to	O
the	O
eccentric	O
nature	O
of	O
the	O
regurgitant	O
jet,	O
its	O
severity	O
may	O
be	O
significantly	O
underestimated	O
(Coanda	O
effect).	O
Moderate	O
to	O
severe	O
[3+]	O
tricuspid	O
regurgitation	O
is	O
seen.	O
There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
[In	O
the	O
setting	O
of	O
at	O
least	O
moderate	O
to	O
severe	O
tricuspid	O
regurgitation,	O
the	O
estimated	O
pulmonary	O
artery	O
systolic	O
pressure	O
may	O
be	O
underestimated	O
due	O
to	O
a	O
very	O
high	O
right	O
atrial	O
pressure.]	O
The	O
end-diastolic	O
pulmonic	O
regurgitation	O
velocity	O
is	O
increased	O
suggesting	O
pulmonary	O
artery	O
diastolic	O
hypertension.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
.	O
Compared	O
with	O
the	O
findings	O
of	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
the	O
left	O
ventricular	O
ejection	O
fraction	O
is	O
further	O
reduced	O
and	O
the	O
mitral	O
and	O
tricuspid	O
regurgitation	O
are	O
significantly	O
increased.	O
.	O
#	O
ECHO	O
___	O
There	O
is	O
mild	O
to	O
moderate	O
global	O
left	O
ventricular	O
hypokinesis	O
(LVEF	O
=	O
35-40%).	O
The	O
right	O
ventricular	O
cavity	O
is	O
mildly	O
dilated	O
with	O
mild	O
global	O
free	O
wall	O
hypokinesis.	O
There	O
is	O
moderate	O
aortic	O
valve	O
stenosis	O
(valve	O
area	O
1.0-1.2cm2).	O
Mild	O
(1+)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Moderate	O
to	O
severe	O
(3+)	O
mitral	O
regurgitation	O
is	O
seen.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
.	O
IMPRESSION:	O
Moderate	O
calcific	O
aortic	O
stenosis.	O
Mild	O
aortic	O
regurgitaiton.	O
Mild	O
to	O
moderate	O
global	O
left	O
ventricular	O
systolic	O
dysfunction.	O
.	O
Compared	O
with	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
aortic	O
transvalvular	O
gradients	O
have	O
decreased.	O
Aortic	O
regurgitation	O
remains	O
in	O
the	O
mild	O
range.	O
LV	O
systolic	O
function	O
has	O
slightly	O
improved.	O
.	O
CARDIAC	O
CATH	O
FINAL	O
DIAGNOSIS:	O
1.	O
Severe	O
aortic	O
stenosis	O
2.	O
SEvere	O
mitral	O
regurgitation	O
3.	O
Borderline	O
cardiac	O
index	O
4.	O
Successful	O
balloon	O
aortic	O
valvuloplasty	O
with	O
20mm	O
Tyshak	O
II	O
balloon	O
(2	O
inflations)	O
without	O
complication	O
5.	O
Please	O
see	O
note	O
in	O
OMR	O
for	O
full	O
details	O
of	O
RHC	O
and	O
valvuloplasty	O
procedure.	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
F	O
with	O
critical	O
AS,	O
CAD	O
s/p	O
CABG	O
presented	O
with	O
increased	O
DOE	O
and	O
volume	O
overload.	O
.	O
ACTIVE	O
ISSUES	O
#	O
Aortic	O
stenosis	O
Pt	O
has	O
significant	O
aortic	O
stenosis	O
incduced	O
cardiomyopathy.	O
Her	O
presenting	O
exam	O
was	O
notable	O
for	O
significant	O
both	O
right	O
and	O
left	O
heart	O
failure,	O
with	O
significant	O
pulmonary	O
edema	O
causing	O
respiratory	O
distress.	O
Pt	O
was	O
treated	O
with	O
lasix	O
gtt,	O
which	O
she	O
tolerated	O
well	O
with	O
daily	O
negative	O
___	O
liters.	O
Her	O
pulmonary	O
edema	O
was	O
further	O
treated	O
with	O
left	O
side	O
thoracentesis	O
with	O
pigtail	O
drainage.	O
Approximately	O
2L	O
serous	O
fluid	O
were	O
drained	O
in	O
24	O
hours.	O
Afterwards,	O
pt	O
underwent	O
a	O
left	O
sided	O
catheterization	O
with	O
valvuloplasty,	O
with	O
improvement	O
of	O
mean	O
aortic	O
valve	O
gradient	O
by	O
~50%.	O
However,	O
pt	O
was	O
also	O
found	O
to	O
have	O
worsening	O
of	O
her	O
dialated	O
cardiomyopathy	O
as	O
well	O
as	O
MR,	O
TR.	O
Because	O
of	O
these	O
reasons,	O
pt	O
was	O
found	O
not	O
a	O
candidate	O
for	O
TAVI/COREVALE.	O
We	O
started	O
her	O
on	O
torsemide	O
40	O
mg	O
daily,	O
and	O
her	O
IN/OUTs	O
have	O
been	O
stable	O
on	O
this	O
regimen.	O
Of	O
note,	O
pt's	O
admission	O
weight	O
was	O
55	O
kg,	O
her	O
discharge	O
weight	O
was	O
50	O
kg,	O
her	O
lowest	O
weight	O
during	O
this	O
admission	O
was	O
47	O
kg.	O
.	O
#	O
CAD:	O
Pt	O
has	O
CAD	O
s/p	O
CABG	O
___	O
years	O
ago.	O
Recent	O
Cath	O
in	O
___	O
showed	O
patent	O
grafts.	O
Her	O
EKG	O
was	O
negative	O
and	O
cardiac	O
enzymes	O
were	O
negative.	O
We	O
continued	O
her	O
aspirin	O
81	O
mg	O
qd.	O
.	O
#	O
Atrial	O
fibrillation:	O
Pt	O
had	O
atrial	O
fibrillation	O
after	O
valvulaplasty	O
in	O
___	O
and	O
was	O
started	O
on	O
amiodarone	O
and	O
coumadin.	O
Her	O
coumadin	O
was	O
d/c'ed	O
in	O
___	O
given	O
she	O
was	O
already	O
in	O
sinus	O
and	O
the	O
afib	O
was	O
likely	O
a	O
post-cath	O
event.	O
We	O
also	O
discontinued	O
her	O
amiodarone	O
during	O
this	O
admission.	O
.	O
#	O
Volume	O
contraction	O
alkalosis:	O
Pt	O
presented	O
with	O
elevated	O
bicarbonate,	O
which	O
worsened	O
with	O
active	O
diuresis.	O
She	O
was	O
treated	O
temporarily	O
was	O
acetozalomide	O
and	O
her	O
bicarb	O
improved	O
to	O
39	O
on	O
the	O
day	O
of	O
discharge.	O
.	O
#	O
Decubitus	B-Pressure_injury
ulcer:	B-Pressure_injury
Pt	O
has	O
a	O
new	O
stage	O
1	O
decubitus	B-Pressure_injury
ulcer	B-Pressure_injury
over	O
the	O
sacrum.	O
The	O
ulcer	B-Pressure_injury
was	O
treated	O
with	O
standard	O
wound	B-Pressure_injury
care	O
and	O
no	O
complication	O
was	O
observed.	O
.	O
CHRONIC	O
ISSUES	O
#	O
DM2:	O
Pt	O
has	O
documented	O
type	O
2	O
diabetes,	O
and	O
takes	O
metformin	O
at	O
home.	O
We	O
held	O
oral	O
meds	O
and	O
started	O
sliding	O
scale	O
insulin.	O
.	O
#	O
Hypothyroidism:	O
cont'ed	O
levothyroxine	O
75	O
mcg	O
qd	O
.	O
#	O
HLD:	O
cont'ed	O
simvastatin	O
40	O
qd	O
.	O
#	O
GERD:	O
cont'ed	O
zofran	O
q6	O
prn	O
.	O
TRANSITIONAL	O
ISSUES	O
#	O
GOAL	O
OF	O
CARE:	O
As	O
pt	O
is	O
no	O
longer	O
a	O
candidate	O
for	O
either	O
surgical	O
management	O
or	O
___	O
for	O
her	O
critical	O
aortic	O
stenosis,	O
discussion	O
around	O
goal	O
of	O
care	O
was	O
raised	O
among	O
patient,	O
her	O
family	O
as	O
well	O
as	O
primary	O
care	O
team,	O
her	O
cardiologist	O
Dr.	O
___	O
team	O
and	O
palliative	O
care	O
team.	O
Going	O
home	O
with	O
hospice	O
care	O
was	O
decision	O
that	O
patient	O
and	O
her	O
family	O
choose.	O
We	O
arranged	O
hospice	O
service	O
and	O
made	O
medication	O
changes	O
accordingly	O
after	O
that.	O
#	O
CODE:	O
DNR/DNI	O
(confirmed	O
with	O
HCP)	O
#	O
CONTACT:	O
___	O
(daughter,	O
HCP)	O
___	O
;	O
___	O
(C)	O
#	O
PENDING	O
STUDIES	O
AT	O
DISCHARGE:	O
None	O
#	O
MEDICATION	O
CHANGES:	O
-	O
DISCONTINUE	O
simvastatin,	O
alendronate,	O
amiodarone,	O
ranitidine,	O
furosemide	O
-	O
CONTINUE	O
aspirin,	O
levothyroxine,	O
zofran	O
prn,	O
ferrous	O
sulfate	O
(per	O
family	O
request),	O
trazadone,	O
metformin	O
-	O
START	O
Torsemide	O
50	O
mg	O
qd	O
-	O
START	O
miralax	O
prn	O
for	O
constipation	B-Constipation
-	O
START	O
morphine	O
___	O
mg	O
sl	O
prn	O
for	O
pain	O
-	O
START	O
lorazepam	O
0.5-1	O
mg	O
q6h	O
for	O
anxiety	O
/	O
insomnia	O
#	O
FOLLOWUP	O
PLAN	O
-	O
Pt	O
will	O
go	O
home	O
with	O
hospice	O
-	O
Dr.	O
___	O
continue	O
to	O
be	O
the	O
primary	O
care	O
physician	O
while	O
pt	O
is	O
on	O
hospice	O
-	O
Will	O
replete	O
potassium	O
as	O
needed	O
as	O
pt	O
is	O
on	O
torsemide	O
-	O
Pt	O
has	O
a	O
foley,	O
which	O
should	O
be	O
discontinued	O
after	O
arriving	O
home	O
-	O
Pt	O
has	O
a	O
decubitous	B-Pressure_injury
ulcer	B-Pressure_injury
over	O
the	O
sacrum,	O
that	O
requires	O
wound	B-Pressure_injury
care	O
Medications	O
on	O
Admission:	O
-	O
simvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
-	O
alendronate	O
70	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
week:	O
give	O
on	O
___.	O
-	O
metformin	O
850	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day:	O
give	O
after	O
lunch.	O
-	O
levothyroxine	O
75	O
mcg	O
qd	O
-	O
amiodarone	O
200	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
at	O
bedtime:	O
-	O
multivitamin	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
-	O
cholecalciferol	O
(vitamin	O
D3)	O
1,000	O
unit	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
at	O
bedtime.	O
-	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
-	O
ranitidine	O
HCl	O
150	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
at	O
bedtime.	O
-	O
furosemide	O
100	O
mg	O
po	O
qAM	O
(started	O
___	O
Please	O
start	O
once	O
diarrhea	O
is	O
resolved.	O
-	O
tylenol	O
___	O
mg	O
q4h	O
prn	O
pain/fever	O
-	O
zofran	O
4	O
mg	O
po	O
q6h	O
prn	O
nausea	O
-	O
duoneb	O
HHN	O
q4h	O
prn	O
for	O
SOB	O
-	O
artificial	O
tears	O
1	O
drop	O
to	O
each	O
eye	O
bid	O
-	O
ferrous	O
sulfate	O
300	O
mg	O
(60	O
mg	O
iron)	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day):	O
after	O
lunch	O
and	O
dinner.	O
-	O
docusate	O
sodium	O
100	O
mg	O
bid	O
prn	O
-	O
bisacodyl	O
10	O
mg	O
suppos	O
PR	O
prn	O
constipation	B-Constipation
-	O
MOM	O
30	O
ml	O
prn	O
constipation	B-Constipation
-	O
maalox	O
30	O
ml	O
q8h	O
prn	O
nausea	O
-	O
trazadone	O
12.5	O
mg	O
qhs	O
-	O
NOT	O
on	O
NS	O
med	O
list,	O
on	O
d/c	O
summary	O
___:	O
lisinopril	O
2.5	O
mg	O
qd	O
Discharge	O
Medications:	O
1.	O
morphine	O
concentrate	O
100	O
mg/5	O
mL	O
(20	O
mg/mL)	O
Solution	O
Sig:	O
___	O
mg	O
PO	O
q1h	O
as	O
needed	O
for	O
pain:	O
please	O
provide	O
sublingual.	O
Disp:*30	O
ml*	O
Refills:*5*	O
2.	O
trazodone	O
50	O
mg	O
Tablet	O
Sig:	O
0.25	O
Tablet	O
PO	O
at	O
bedtime:	O
___	O
take	O
additional	O
0.25	O
tablet	O
if	O
insomnia.	O
Disp:*30	O
Tablet(s)*	O
Refills:*5*	O
3.	O
Ativan	O
0.5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
every	O
six	O
(6)	O
hours	O
as	O
needed	O
for	O
anxiety,	O
insomnia:	O
___	O
repeat	O
once	O
in	O
30	O
mins;	O
Please	O
hold	O
for	O
sedation	O
or	O
RR	O
<	O
10.	O
Disp:*30	O
Tablet(s)*	O
Refills:*0*	O
4.	O
ferrous	O
sulfate	O
325	O
mg	O
(65	O
mg	O
iron)	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
5.	O
torsemide	O
20	O
mg	O
Tablet	O
Sig:	O
2.5	O
Tablets	O
PO	O
DAILY	O
(Daily).	O
6.	O
levothyroxine	O
75	O
mcg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
7.	O
docusate	O
sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
8.	O
ondansetron	O
4	O
mg	O
Tablet,	O
Rapid	O
Dissolve	O
Sig:	O
One	O
(1)	O
Tablet,	O
Rapid	O
Dissolve	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed	O
for	O
nausea.	O
9.	O
polyethylene	O
glycol	O
3350	O
17	O
gram/dose	O
Powder	O
Sig:	O
One	O
(1)	O
PO	O
DAILY	O
(Daily)	O
as	O
needed	O
for	O
constipation.	B-Constipation
10.	O
acetaminophen	O
500	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
Q	O
8H	O
(Every	O
8	O
Hours).	O
11.	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
12.	O
metformin	O
850	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day:	O
Take	O
one	O
tablet	O
after	O
lunch.	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary	O
diagnosis	O
-	O
Aortic	O
stenosis	O
Secondary	O
diagnosis	O
-	O
mitral	O
regurgitation	O
-	O
atrial	O
fibrillation	O
-	O
osteoporosis	O
-	O
breast	O
cancer	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	B-Mobile_with_assistance
chair	B-Mobile_with_assistance
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
___,	O
___	O
were	O
transferred	O
to	O
our	O
hospital	O
for	O
worsening	O
shortness	O
of	O
breath	O
and	O
swelling.	O
The	O
cause	O
of	O
your	O
symptom	O
is	O
because	O
a	O
tight	O
heart	O
valve,	O
called	O
"aortic	O
stenosis",	O
leading	O
to	O
fluid	O
accumulation.	O
___	O
were	O
treated	O
with	O
intravenous	O
medication	O
for	O
fluid	O
removal,	O
which	O
___	O
tolerated	O
very	O
well.	O
We	O
also	O
placed	O
a	O
drainage	O
tube	O
over	O
your	O
left	O
lung	O
to	O
expedite	O
removal	O
of	O
the	O
fluid	O
in	O
your	O
lung.	O
___	O
underwent	O
a	O
procedure	O
called	O
valvuloplasty,	O
which	O
___	O
had	O
before	O
and	O
tolerated	O
very	O
well	O
this	O
time.	O
Given	O
the	O
progression	O
of	O
your	O
condition,	O
a	O
decision	O
was	O
made	O
by	O
___	O
and	O
your	O
family	O
to	O
shift	O
the	O
focus	O
of	O
care	O
to	O
comfort.	O
We	O
invited	O
our	O
colleagues	O
from	O
___	O
care	O
to	O
assist	O
us	O
with	O
the	O
management	O
of	O
your	O
care.	O
As	O
your	O
condition	O
has	O
been	O
stable,	O
___	O
will	O
go	O
home	O
with	O
hospice	O
service.	O
Please	O
note	O
that	O
the	O
medication	O
has	O
changed	O
a	O
lot	O
-	O
Please	O
START	O
to	O
take	O
Torsemide	O
50	O
mg	O
tablet	O
by	O
mouth	O
in	O
the	O
morning	O
once	O
a	O
day	O
-	O
Please	O
START	O
to	O
take	O
miralax	O
17	O
g	O
packet	O
once	O
a	O
day	O
as	O
needed	O
for	O
constipation	B-Constipation
-	O
Please	O
START	O
to	O
take	O
lorazepam	O
0.5-1	O
mg	O
every	O
6	O
hours	O
for	O
anxiety	O
or	O
insomnia	O
-	O
Please	O
START	O
to	O
take	O
morphine	O
sulfate	O
sulution	O
___	O
mg	O
under	O
the	O
tongue	O
every	O
hour	O
as	O
needed	O
for	O
pain	O
and	O
respiratory	O
distress	O
-	O
Please	O
CONTINUE	O
to	O
take	O
aspirin	O
81	O
mg	O
tablet	O
once	O
a	O
day	O
-	O
Please	O
CONTINUE	O
to	O
take	O
Colace	O
100	O
mg	O
tablet	O
twice	O
a	O
day	O
-	O
Please	O
CONTINUE	O
to	O
take	O
levothyroxine	O
75	O
mcg	O
tablet	O
once	O
a	O
day	O
-	O
Please	O
CONTINUE	O
to	O
take	O
metformin	O
850	O
mg	O
tablet	O
once	O
after	O
lunch	O
daily	O
-	O
Please	O
CONTINUE	O
to	O
take	O
Zofran	O
4	O
mg	O
tablet	O
every	O
6	O
hours	O
as	O
needed	O
for	O
nausea	O
-	O
Please	O
CONTINUE	O
trazadone	O
12.5	O
mg	O
tablet	O
by	O
mouth	O
before	O
bed,	O
and	O
may	O
repeat	O
once	O
if	O
necessary	O
for	O
insomnia	O
-	O
Please	O
STOP	O
taking	O
the	O
rest	O
of	O
your	O
previous	O
medication.	O
.	O
It	O
has	O
been	O
a	O
pleasure	O
taking	O
care	O
of	O
___	O
here	O
at	O
___.	O
We	O
wish	O
___	O
a	O
speedy	O
recovery.	O
Weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
Followup	O
Instructions:	O
___	O

